FORUM is a randomized, controlled, open-label, international, multicenter, phase III, noninferiority study. Patients ≤ 18 years at diagnosis, 4-21 years at HSCT, in complete remission pre-HSCT, and ...
Please provide your email address to receive an email when new articles are posted on . Allogeneic hematopoietic stem cell transplants with total body irradiation and etoposide vs. chemotherapy-based ...
Please provide your email address to receive an email when new articles are posted on . Total body irradiation plus etoposide improved OS and appeared to reduce risk for relapse among children with ...
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results